White House Unveils Actions To Speed Precision Medicine
This article was originally published in Scrip
Executive Summary
The White House on Feb. 25 unveiled new actions and commitments from government agencies, including the National Institutes of Health (NIH) and the FDA, and private-sector participants, including Pfizer Inc. and Roche AG unit Genentech Inc., aimed at speeding President Barack Obama's Precision Medicine Initiative (PMI) forward.